Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Neal Moreau Spears
mi
from
Smithville, TX
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Neal Moreau Spears
mi
from
Smithville, TX
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Tykes to Teens Pediatrics
mi
from
Sugar Land, TX
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Tykes to Teens Pediatrics
mi
from
Sugar Land, TX
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Pediatric Healthcare of NW Houston, Pa
mi
from
Tomball, TX
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Pediatric Healthcare of NW Houston, Pa
mi
from
Tomball, TX
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Dixie Pediatrics
mi
from
Saint George, UT
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Dixie Pediatrics
mi
from
Saint George, UT
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Jordan Valley Pediatrics
mi
from
West Jordan, UT
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Jordan Valley Pediatrics
mi
from
West Jordan, UT
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Van Dorn Pediatrics
mi
from
Alexandria, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Van Dorn Pediatrics
mi
from
Alexandria, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
M T Curry, Inc.
mi
from
Chesapeake, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
M T Curry, Inc.
mi
from
Chesapeake, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Wiley & Arkin Pediatrics, LLC
mi
from
Glen Allen, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Wiley & Arkin Pediatrics, LLC
mi
from
Glen Allen, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Pediatric and Adolescent Health Partners, Pc
mi
from
Midlothian, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Pediatric and Adolescent Health Partners, Pc
mi
from
Midlothian, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Huguenot Pediatrics
mi
from
Midlothian, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Huguenot Pediatrics
mi
from
Midlothian, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Virginia Commonwealth University Medical
mi
from
Richmond, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Virginia Commonwealth University Medical
mi
from
Richmond, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Chippenham Pediatric and Adolescent Medicine, PC
mi
from
Richmond, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Chippenham Pediatric and Adolescent Medicine, PC
mi
from
Richmond, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Nova Pediatrics, Ltd
mi
from
Springfield, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Nova Pediatrics, Ltd
mi
from
Springfield, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Advanced Pediatrics
mi
from
Vienna, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Advanced Pediatrics
mi
from
Vienna, VA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Northwest Pediatric Center, Inc., PS
mi
from
Centralia, WA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Northwest Pediatric Center, Inc., PS
mi
from
Centralia, WA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Premier Clinical Research
mi
from
Spokane, WA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Premier Clinical Research
mi
from
Spokane, WA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Woodinville Pediatrics
mi
from
Woodinville, WA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Woodinville Pediatrics
mi
from
Woodinville, WA
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Charleston Area Medical Center
mi
from
Charleston, WV
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Charleston Area Medical Center
mi
from
Charleston, WV
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Gundersen Clinic
mi
from
LaCrosse, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Gundersen Clinic
mi
from
LaCrosse, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
University of Wisconsin-Madison
mi
from
Madison, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
University of Wisconsin-Madison
mi
from
Madison, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Medical College of Wisconsin
mi
from
Milwaukee, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Medical College of Wisconsin
mi
from
Milwaukee, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Monroe Clinic
mi
from
Monroe, WI
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Status: Archived
Updated: 1/1/1970
Monroe Clinic
mi
from
Monroe, WI
Family Eats:Cancer Prevention for Families
Family Eats:Cancer Prevention for Families
Status: Archived
Children's National Medical Center--Pediatric Clinic
mi
from
Washington,
Family Eats:Cancer Prevention for Families
Family Eats:Cancer Prevention for Families
Status: Archived
Updated: 1/1/1970
Children's National Medical Center--Pediatric Clinic
mi
from
Washington,
Energy Expenditure Responses to Acute Exercise in Older Women (Calorie Expenditure and Exercise)
Energy Expenditure Responses to Acute Exercise in Older Women
Status: Archived
Washington University
mi
from
St. Louis, MO
Energy Expenditure Responses to Acute Exercise in Older Women (Calorie Expenditure and Exercise)
Energy Expenditure Responses to Acute Exercise in Older Women
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Cotinine Metabolism in Infants and Children
Cotinine Metabolism in Infants and Children
Status: Archived
UCLA Medical Center
mi
from
Los Angeles, CA
Cotinine Metabolism in Infants and Children
Cotinine Metabolism in Infants and Children
Status: Archived
Updated: 1/1/1970
UCLA Medical Center
mi
from
Los Angeles, CA
Resistant Starch Insulin Sensitivity Trial
Effects of Resistant Starch on Lipid and Glucose Metabolism in Insulin Resistance
Status: Archived
Cholesterol Research Center
mi
from
Berkeley, CA
Resistant Starch Insulin Sensitivity Trial
Effects of Resistant Starch on Lipid and Glucose Metabolism in Insulin Resistance
Status: Archived
Updated: 1/1/1970
Cholesterol Research Center
mi
from
Berkeley, CA
Resistant Starch Insulin Sensitivity Trial
Effects of Resistant Starch on Lipid and Glucose Metabolism in Insulin Resistance
Status: Archived
Children's Hospital
mi
from
Pittsburgh, PA
Resistant Starch Insulin Sensitivity Trial
Effects of Resistant Starch on Lipid and Glucose Metabolism in Insulin Resistance
Status: Archived
Updated: 1/1/1970
Children's Hospital
mi
from
Pittsburgh, PA
A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects
A Randomized, Double-Blind, Placebo-Controlled, Sequential Dose Escalation Study of the Safety, Pharmacodynamics and Pharmacokinetics of Single Intravenous Doses of HM10760A in Healthy Adult Caucasian and Japanese Subjects
Status: Archived
California Clinical Trials
mi
from
Glendale, CA
A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects
A Randomized, Double-Blind, Placebo-Controlled, Sequential Dose Escalation Study of the Safety, Pharmacodynamics and Pharmacokinetics of Single Intravenous Doses of HM10760A in Healthy Adult Caucasian and Japanese Subjects
Status: Archived
Updated: 1/1/1970
California Clinical Trials
mi
from
Glendale, CA
Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, and PK of HM10460A (HNK460) When Administered Subcutaneously to Healthy Adult Japanese and Caucasian Subjects.
Status: Archived
California Clinical Trials
mi
from
Glendale, CA
Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, and PK of HM10460A (HNK460) When Administered Subcutaneously to Healthy Adult Japanese and Caucasian Subjects.
Status: Archived
Updated: 1/1/1970
California Clinical Trials
mi
from
Glendale, CA
Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults
Neural Effects of Exercise, Cognitive, or Combined Training in AD At-Risk Elders
Status: Archived
The Cleveland Clinic
mi
from
Cleveland, OH
Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults
Neural Effects of Exercise, Cognitive, or Combined Training in AD At-Risk Elders
Status: Archived
Updated: 1/1/1970
The Cleveland Clinic
mi
from
Cleveland, OH
BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
A Randomized, Blinded, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB033 in Healthy Adult Volunteers
Status: Archived
Clinical Research Facility
mi
from
San Diego, CA
BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
A Randomized, Blinded, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB033 in Healthy Adult Volunteers
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
San Diego, CA
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days
A Phase I, Single Center, Double-blind Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Intravenous AZD9742 After Administration of Multiple Ascending Doses for 14 Days in Healthy Male and Female Subjects
Status: Archived
Clinical Research Facility
mi
from
Kansas City, KA
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days
A Phase I, Single Center, Double-blind Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Intravenous AZD9742 After Administration of Multiple Ascending Doses for 14 Days in Healthy Male and Female Subjects
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, KA
Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers
A Phase 1, Placebo-Controlled, Multiple-Dose Escalation Trial Evaluating The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-04308515 (Part 1), And A Single Dose Pharmacokinetic Assessment Of A PF-04308515 Tablet Formulation (Part 2), In Healthy Volunteers
Status: Archived
Pfizer Investigational Site
mi
from
Bridgeport, CT
Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers
A Phase 1, Placebo-Controlled, Multiple-Dose Escalation Trial Evaluating The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-04308515 (Part 1), And A Single Dose Pharmacokinetic Assessment Of A PF-04308515 Tablet Formulation (Part 2), In Healthy Volunteers
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Bridgeport, CT
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
Status: Archived
University of Colorado, Boulder
mi
from
Boulder, CO
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
Status: Archived
Updated: 1/1/1970
University of Colorado, Boulder
mi
from
Boulder, CO
A Single-Dose, PK/PD, & Safety Study of BIIB017 in Subjects With Renal Impairment & Healthy Volunteers
An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment
Status: Archived
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Single-Dose, PK/PD, & Safety Study of BIIB017 in Subjects With Renal Impairment & Healthy Volunteers
An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Single-Dose, PK/PD, & Safety Study of BIIB017 in Subjects With Renal Impairment & Healthy Volunteers
An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment
Status: Archived
Clinical Research Facility
mi
from
Duluth, MN
A Single-Dose, PK/PD, & Safety Study of BIIB017 in Subjects With Renal Impairment & Healthy Volunteers
An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Duluth, MN
A Single-Dose, PK/PD, & Safety Study of BIIB017 in Subjects With Renal Impairment & Healthy Volunteers
An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
A Single-Dose, PK/PD, & Safety Study of BIIB017 in Subjects With Renal Impairment & Healthy Volunteers
An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
DCVax Plus Poly ICLC in Healthy Volunteers
A Randomized, Placebo-controlled, Dose-escalating, Double-blinded Phase I Study to Evaluate the Safety and Immunogenicity of Anti-DEC-205 Monoclonal Antibody (Mab) Targeted HIV Gag p24 Vaccine (DCVax-001) With Poly ICLC (Hiltonol) as Adjuvant in HIV-uninfected Healthy Volunteers
Status: Archived
The Rockefeller University Hospital
mi
from
New York, NY
DCVax Plus Poly ICLC in Healthy Volunteers
A Randomized, Placebo-controlled, Dose-escalating, Double-blinded Phase I Study to Evaluate the Safety and Immunogenicity of Anti-DEC-205 Monoclonal Antibody (Mab) Targeted HIV Gag p24 Vaccine (DCVax-001) With Poly ICLC (Hiltonol) as Adjuvant in HIV-uninfected Healthy Volunteers
Status: Archived
Updated: 1/1/1970
The Rockefeller University Hospital
mi
from
New York, NY
Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study
Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study
Status: Archived
Cognitive Motor Movement Neuroscience Lab (CoMMoNS) - rm 3612 NCB, Drexel University
mi
from
Philadelphia, PA
Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study
Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study
Status: Archived
Updated: 1/1/1970
Cognitive Motor Movement Neuroscience Lab (CoMMoNS) - rm 3612 NCB, Drexel University
mi
from
Philadelphia, PA
Development of a Biomarker for Dietary Furanocoumarins
Development of a Biomarker for Dietary Furanocoumarins
Status: Archived
Cornell University, Weill Medical College
mi
from
New York, NY
Development of a Biomarker for Dietary Furanocoumarins
Development of a Biomarker for Dietary Furanocoumarins
Status: Archived
Updated: 1/1/1970
Cornell University, Weill Medical College
mi
from
New York, NY
Physiology of Volition Studied With Nerve Block
Physiology of Volition Studied With Nerve Block
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Physiology of Volition Studied With Nerve Block
Physiology of Volition Studied With Nerve Block
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Safety and Tolerability Study of N6022 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effect of N6022 in Healthy Subjects
Status: Archived
Parexel Early Phase Unit
mi
from
Baltimore, MD
Safety and Tolerability Study of N6022 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effect of N6022 in Healthy Subjects
Status: Archived
Updated: 1/1/1970
Parexel Early Phase Unit
mi
from
Baltimore, MD
Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion
Comparative Pharmacokinetics, Safety, and Pharmacodynamics of Ertapenem 1 Gram Daily Administered as an IV Bolus Versus Standard 30 Minute Infusion to Healthy Adult Volunteers
Status: Archived
Center for Fertility and Women's Health
mi
from
New Britain, CT
Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion
Comparative Pharmacokinetics, Safety, and Pharmacodynamics of Ertapenem 1 Gram Daily Administered as an IV Bolus Versus Standard 30 Minute Infusion to Healthy Adult Volunteers
Status: Archived
Updated: 1/1/1970
Center for Fertility and Women's Health
mi
from
New Britain, CT
Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects
A Phase 1, Randomized, Subject- and Investigator-blind, Sponsor-open, Placebo-controlled, Single- and Multiple-dose Escalation Study to Investigate the Pharmacokinetics, Safety and Tolerability of PF-03463275 in Healthy Male Japanese and Western Subjects
Status: Archived
Pfizer Investigational Site
mi
from
Los Angeles, CA
Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects
A Phase 1, Randomized, Subject- and Investigator-blind, Sponsor-open, Placebo-controlled, Single- and Multiple-dose Escalation Study to Investigate the Pharmacokinetics, Safety and Tolerability of PF-03463275 in Healthy Male Japanese and Western Subjects
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects
Status: Archived
Pfizer Investigational Site
mi
from
Bridgeport, CT
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Bridgeport, CT
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects
Status: Archived
Pfizer Investigational Site
mi
from
Arkansas City, KA
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Arkansas City, KA
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Youth Reporting Center (Youth Services Center)
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
Youth Reporting Center (Youth Services Center)
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Sandia Preparatory School
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
Sandia Preparatory School
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Albuquerque Academy
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
Albuquerque Academy
mi
from
Albuquerque, NM
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response
Status: Archived
Updated: 1/1/1970
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ